Citizens JMP downgraded Evercore from Mkt Outperform to Mkt Perform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/26/2026 | $435.00 | Buy | BofA Securities |
| 12/11/2025 | $340.00 | Neutral | UBS |
| 12/8/2025 | $373.00 | Overweight → Equal-Weight | Morgan Stanley |
| 10/9/2025 | $400.00 | Buy | Deutsche Bank |
| 10/3/2025 | $358.00 | Market Perform | BMO Capital Markets |
| 7/14/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 6/23/2025 | $312.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/8/2025 | $230.00 | Mkt Perform → Mkt Outperform | Citizens JMP |
SCHEDULE 13G/A - Evercore Inc. (0001360901) (Subject)
10-K - Evercore Inc. (0001360901) (Filer)
SCHEDULE 13G/A - Evercore Inc. (0001360901) (Subject)
Evercore (NYSE:EVR) will release its first quarter 2026 financial results on Wednesday, April 29, 2026 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's first quarter 2026 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 445-7795 (toll-free domestic) or (785) 424-1
Evercore (NYSE:EVR) will host its third annual Private Markets Forum in New York City on May 11-12, 2026. This year's forum will bring together senior leaders and industry specialists from about 20 leading private markets asset management firms, alongside a distinguished group of investment professionals from across the sector. Glenn Schorr, senior research analyst, said, "We are at a pivotal moment for asset management. As capital formation increasingly shifts toward private markets, the industry is evolving in ways we have not seen before." Marc Harris, director of global macro and fundamental research at Evercore, said, "At a time when private markets are at the center of some of the
Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further
3 - Evercore Inc. (0001360901) (Issuer)
4 - Evercore Inc. (0001360901) (Issuer)
4 - Evercore Inc. (0001360901) (Issuer)
4 - Evercore Inc. (0001360901) (Issuer)
BofA Securities initiated coverage of Evercore with a rating of Buy and set a new price target of $435.00
UBS resumed coverage of Evercore with a rating of Neutral and set a new price target of $340.00
Morgan Stanley downgraded Evercore from Overweight to Equal-Weight and set a new price target of $373.00
Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further
Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. "We are pleased to welcome Ben to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform." "We are excited to have Ben join the firm," said Francois Maisonrouge, chairman of Evercore's global healthcare group. "Biopharma is one of the most dynamic areas in global healthcare. Continuing to deepen our presence in this
Evercore (NYSE:EVR) announced today that Ben Hart has joined the firm as a senior managing director and head of its Asia Private Capital Advisory (PCA) division. Based in Singapore, Mr. Hart will oversee Evercore PCA's activities across the Asia-Pacific region and work closely with the global PCA team to further expand the firm's secondaries advisory and broader private markets capabilities in the region. "We are thrilled to welcome Ben to Evercore," said Nigel Dawn, global head of Evercore's PCA division. "Ben has built an exceptional reputation and deep relationships across Asia's private markets ecosystem. His extensive experience in capital formation and distribution across APAC will
SC 13G/A - Evercore Inc. (0001360901) (Subject)
SC 13G/A - Evercore Inc. (0001360901) (Subject)
SC 13G/A - Evercore Inc. (0001360901) (Subject)
Evercore (NYSE:EVR) will release its first quarter 2026 financial results on Wednesday, April 29, 2026 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's first quarter 2026 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 445-7795 (toll-free domestic) or (785) 424-1
Evercore Inc. (NYSE:EVR): Fourth Quarter Results Full Year Results U.S. GAAP Adjusted U.S. GAAP Adjusted Q4 2025 Q4 2024 Q4 2025 Q4 2024 2025 2024 2025 2024 Net Revenues ($ mm) $ 1,288.3 $ 975.3 $ 1,298.1 $ 980.5 $ 3,855.8 $ 2,979.6 $ 3,884.0 $ 3,002.6 Operating Income
Evercore (NYSE:EVR) will release its fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's fourth quarter and full year 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 245-3047 (to